Nwam LLC Ani Pharmaceuticals Inc Transaction History

Nwam LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 16, 2020	SELL	$26.38 - $33.1 $177,247 - $222,398	-6,719 Closed	0 $0
Q2 2020 Jul 21, 2020	SELL	$29.93 - $50.1 $4,190 - $7,014	-140 Reduced 2.04%	6,719 $217,000
Q1 2020 Apr 16, 2020	SELL	$30.35 - $67.14 $6,070 - $13,428	-200 Reduced 2.83%	6,859 $279,000
Q3 2019 Oct 15, 2019	SELL	$64.7 - $85.39 $25,880 - $34,156	-400 Reduced 5.36%	7,059 $514,000
Q2 2019 Jul 18, 2019	SELL	$67.77 - $82.2 $29,818 - $36,168	-440 Reduced 5.57%	7,459 $613,000
Q1 2019 Apr 17, 2019	SELL	$45.83 - $70.54 $6,416 - $9,875	-140 Reduced 1.74%	7,899 $557,000
Q4 2018 Jan 30, 2019	BUY	$41.17 - $56.44 $205 - $282	5 Added 0.06%	8,039 $362,000
Q3 2018 Oct 09, 2018	SELL	$52.95 - $71.34 $30,446 - $41,020	-575 Reduced 6.68%	8,034 $454,000
Q2 2018 Jul 16, 2018	SELL	$56.38 - $68.08 $16,801 - $20,287	-298 Reduced 3.35%	8,609 $575,000
Q1 2018 Apr 16, 2018	SELL	$56.98 - $72.41 $49,743 - $63,213	-873 Reduced 8.93%	8,907 $519,000
Q4 2017 Feb 07, 2018	SELL	$53.3 - $74.56 $113,635 - $158,961	-2,132 Reduced 17.9%	9,780 $630,000
Q3 2017 Nov 01, 2017	BUY	$43.46 - $52.49 $517,695 - $625,260	11,912	11,912 $625,000

211

18.8M

11.7K

10.5K

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $986M
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

Get notified when there are updates to the investment portfolio of Nwam LLC, based on Form 13F filings with the SEC.

Stay updated on Nwam LLC with notifications on news.